CCG-63808 is primarily utilized in research settings as a selective inhibitor for specific biological targets, particularly in the study of cellular signaling pathways. It is often employed in pharmacological studies to investigate the role of certain enzymes or receptors in disease models, aiding in the understanding of molecular mechanisms and potential therapeutic interventions. Its application is significant in the development of novel drugs, as it helps researchers identify and validate new targets for treating various conditions, such as cancer, neurological disorders, or inflammatory diseases. Additionally, CCG-63808 is used in high-throughput screening assays to evaluate the efficacy and specificity of new compounds, contributing to the advancement of medicinal chemistry and drug discovery.